(Q47379090)

15 January 2018

title

Prognostic impact of p63 and p53 expression in upper urinary tract transitional cell carcinoma (English)

1 reference

15 January 2018

author name string

Richard Zigeuner

1

1 reference

15 January 2018

Oleksiy Tsybrovskyy

2

1 reference

15 January 2018

Manfred Ratschek

3

1 reference

15 January 2018

Peter Rehak

4

1 reference

15 January 2018

Katja Lipsky

5

1 reference

15 January 2018

Cord Langner

6

1 reference

15 January 2018

language of work or name

English

0 references

publication date

1 June 2004

1 reference

15 January 2018

published in

Urology

1 reference

15 January 2018

volume

63

1 reference

15 January 2018

issue

6

1 reference

15 January 2018

page(s)

1079-1083

1 reference

15 January 2018

Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.01.009

Analysis of the performance of pathologists in the grading of bladder tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.01.009

p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.01.009

p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.01.009

Loss of p63 expression is associated with tumor progression in bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.01.009

p63 immunoreactivity in lung cancer: yet another player in the development of squamous cell carcinomas?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.01.009

Impaired Delta Np63 expression associates with reduced beta-catenin and aggressive phenotypes of urothelial neoplasms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.01.009

The p53 tumour suppressor gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.01.009

Immunohistochemical evaluation of p53 oncoprotein in transitional cell carcinoma of the upper urinary tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.01.009

Overexpression of p53 in transitional cell carcinoma of the renal pelvis and ureter. Relation to tumor proliferation and survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.01.009

Tissue microarrays for high-throughput molecular profiling of tumor specimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.01.009

Immunohistochemical detection of p53 protein overexpression versus gene sequencing in urinary bladder carcinomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.01.009

Structural alteration of p53 protein in patients with muscle invasive bladder transitional cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.01.009

The predictive value of muscularis mucosae invasion and p53 over expression on progression of stage T1 bladder carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.01.009

Immunohistochemistry of p53 protein in transitional-cell carcinoma of the bladder using an image analyzer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.01.009

Clinical significance of mdm2 and p53 expression in bladder cancer. A comparison with cell proliferation and apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.01.009

p53 nuclear accumulation is not associated with decreased disease-free survival in patients with node positive transitional cell carcinoma of the bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.01.009

10.1016/J.UROLOGY.2004.01.009

7 January 2021

Identifiers

DOI

1 reference

15 January 2018

1 reference

15 January 2018